An interventional study of Web-Based Psychoeducation and Symptom-Monitoring Program in Dementia, sponsored by Lotung Poh-Ai Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-09-23.
Sponsored by Lotung Poh-Ai Hospital · Not applicable, Interventional, and Supportive care
Behavioral and psychological symptoms of dementia (BPSD), such as agitation, anxiety, depression, sleep disturbance, and apathy, are common among people with dementia and often increase the burden on family caregivers. Many caregivers have limited knowledge and confidence in managing these symptoms.
This study aims to evaluate the effectiveness of a 6-week web-based psychoeducation and BPSD symptom-monitoring program in improving caregivers' self-efficacy in managing BPSD. Community-dwelling family caregivers of people with dementia will be recruited through healthcare, care, or community service settings and related activities in Taiwan.
Participants will be assigned sequentially to either an intervention group receiving web-based psychoeducation, BPSD symptom monitoring, and usual care, or a control group receiving usual care alone. The primary outcome is caregiver self-efficacy. Secondary outcomes include BPSD severity and caregiver burden.
Behavioral and psychological symptoms of dementia (BPSD) affect many people living with dementia during the course of the disease and are associated with increased caregiver burden, psychological distress, and reduced quality of life. Family caregivers frequently experience difficulties in recognizing BPSD, identifying possible triggers, and applying appropriate management strategies. Although web-based psychoeducation has shown potential benefits for dementia caregivers, evidence regarding its effectiveness in improving caregiver self-efficacy through the integration of structured symptom monitoring remains limited.
This study will evaluate a six-week web-based psychoeducation and BPSD symptom-monitoring program developed for family caregivers of community-dwelling people with dementia. The intervention is delivered through an AppSheet-based online platform and includes web-based educational modules and BPSD symptom diary recording. The symptom diary allows caregivers to record symptom types, circumstances, possible triggers, management strategies, and outcomes. Educational topics include understanding dementia, recognition of BPSD and possible triggers, BPSD management and caregiving strategies, communication and home care, caregiver self-care, and community support resources.
This study uses a quasi-experimental two-group pretest-posttest parallel design. Approximately 80 family caregivers will be recruited through healthcare, care, or community service settings and related activities in Taiwan. Participants will be assigned sequentially in alternating order to either the intervention group or the usual care control group.
Outcome assessments will be conducted at baseline (Week 0) and after the six-week intervention (Week 6) for both groups. Participants in the intervention group will additionally complete a follow-up assessment at Week 10 to evaluate maintenance of intervention effects.
The primary outcome is caregiver self-efficacy measured using the Revised Scale for Caregiving Self-Efficacy (RSCSE). Secondary outcomes include BPSD measured using the Neuropsychiatric Inventory Questionnaire (NPI-Q) and caregiver burden measured using the Zarit Burden Interview (ZBI).
2,372 studies on the registry are indexed under Dementia; 574 are open to participants now.
This study's planned enrollment of 80 is below the median of 90 across 1,758 interventional studies indexed under Dementia.
Browse Dementia studies →Lotung Poh-Ai Hospital is the lead sponsor of 10 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants receive a 6-week web-based psychoeducation and BPSD symptom-monitoring program in addition to usual care. The intervention includes web-based educational content on dementia care and BPSD management, as well as BPSD symptom diary recording.
Behavioral: Web-Based Psychoeducation and Symptom-Monitoring Program
Participants receive usual care without access to the web-based psychoeducation and symptom-monitoring program during the study period.
Participants assigned to the intervention group receive a 6-week web-based psychoeducation and BPSD symptom-monitoring program in addition to usual care. The program provides web-based educational content on dementia care, recognition of BPSD and possible triggers, BPSD management and caregiving strategies, communication and home care, caregiver self-care, and community support resources. Participants may also use the online platform to record BPSD symptoms, circumstances, possible triggers, management strategies, and outcomes. The intervention is designed to improve caregiver self-efficacy in managing behavioral and psychological symptoms of dementia.
Caregiver Self-Efficacy in Managing Behavioral and Psychological Symptoms of Dementia
Caregiver self-efficacy will be assessed using the Revised Scale for Caregiving Self-Efficacy (RSCSE). The primary outcome is the change in caregiver self-efficacy from baseline to Week 6 between the intervention and control groups.
Time frame: Baseline and Week 6
Behavioral and Psychological Symptoms of Dementia
Behavioral and psychological symptoms of dementia will be assessed using the Neuropsychiatric Inventory Questionnaire (NPI-Q). The secondary outcome is the change in symptom severity and caregiver distress from baseline to Week 6 between the intervention and control groups.
Time frame: Baseline and Week 6
Caregiver Burden
Caregiver burden will be assessed using the 22-item Zarit Burden Interview (ZBI-22). The secondary outcome is the change in caregiver burden from baseline to Week 6 between the intervention and control groups.
Time frame: Baseline and Week 6
Plan to share: No — No individual participant data will be shared because informed consent does not include permission for data sharing outside this study.
Started Jul 2026 (actual). Primary completion is estimated for May 2027, 10 months after the start.
Of 855 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 10 months is below that.
Counting every sponsor, half of 901 studies reached it within 25 months; a quarter within 11 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lotung Poh-Ai Hospital